Business Wire

the International Film Criticism Conference Is Launched in Riyadh

8.11.2024 19:06:00 EET | Business Wire | Press release

Share

The Saudi Film Commission announced the commencement of the second edition of the International Film Criticism Conference in Riyadh, running from November 6 to 10, 2024. The conference is distinguished by a vast presence of international filmmakers, critics, and cinephiles.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241108289069/en/

The International Film Criticism Conference is launched in Riyadh (Photo: AETOSWire)

The second edition of the Film Criticism Conference is held under the theme "Sound in Cinema", to explore the various impacts of sound on the film experience and its influence on the film industry. The discussions will cover different elements such as film scores, sound effects, and nature sounds. The conference will also include workshops, film screenings, and interactive exhibits.

The opening ceremony started with an introductory video about the conference, its objectives, and past achievements, followed by a speech by the CEO of the Saudi Film Commission, Mr. Abdullah bin Nasser Al-Qahtani, expressing the idea behind this year’s theme stating that: "The Saudi Film Commission is dedicated to establishing, developing, and sustaining a strong and vibrant film industry, in line with Saudi Vision 2030.” Al-Qahtani also stated that “The Film Commission focuses on empowering criticism as an intellectual and artistic tool that illuminates the path of cinema and opens new prospects for it." He adds, "From this perspective, this conference has been created as a platform to bring together critics and cinematic innovators, providing them the opportunity to exchange ideas and experiences, ultimately leading to the formation of a deeper Arabic cinematic awareness that elevates our film sector to international levels, while staying true our authentic culture and identity."

The ceremony also included a speech by prominent Saudi director, Mr. Abdullah Al-Mohaisen, who stated: "Film criticism relies on sentient, honest, and purposeful criticism. It is the dynamic driver of development and creativity for the director. Cinema is and will always be a message before being anything else." Al-Mohaisen’s speech was followed by a screening of the film “Assassination of a City”, a pioneering Saudi documentary that won several international awards. A follow-up discussion was held between the director and moderated by film critics Ahmad Shawqi and Ahmad Alayyad.

The International Film Criticism Conference is organized by the Saudi Film Commission. Prior to this conference, two other film criticism events were held this year, Hail on September 27 and Al-Ahsa on October 25.

*Source: AETOSWire

View source version on businesswire.com: https://www.businesswire.com/news/home/20241108289069/en/

Contacts

Nasry Abou Zaki
nasry@jcn.marketing

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 12:47:00 EEST | Press release

Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 11:16:00 EEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye